A prospective 3-year follow-up trial of implantation of two trabecular microbypass stents in open-angle glaucoma

Clinical Ophthalmology

Volumn 9, Issue , 2015, Pages 2057-2065

  Donnenfeld, Eric D ^a   Solomon, Kerry D ^b   Voskanyan, Lilit ^c   Chang, David F ^d   Samuelson, Thomas W ^e   Ahmed, Iqbal Ike K ^f   Katz, L Jay ^g  

^a OPHTHALMIC CONSULTANTS OF LONG ISLAND   (United States)

^b Carolina Eyecare Physicians   (United States)

^c SVMalayan's Ophthalmologic Center   (Armenia)

^d Altos Eye Physicians   (United States)

^e MINNESOTA EYE CONSULTANTS   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g WILLS EYE HOSPITAL   (United States)

Author keywords

Intraocular pressure; IOP reduction; iStent; MIGS; OAG

Indexed keywords

ADULT; AGE RELATED MACULAR DEGENERATION; AGED; ARTICLE; CATARACT; CATARACT EXTRACTION; CONTROLLED STUDY; DEVICE SAFETY; FEMALE; FOLLOW UP; GLAUCOMA SURGERY; HUMAN; HYPHEMA; INTRAOCULAR PRESSURE; MALE; MICROINVASIVE GLAUCOMA SURGERY; OPEN ANGLE GLAUCOMA; OPEN STUDY; OPHTHALMOLOGICAL IMPLANT; PACHYMETRY; PILOT STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROLIFERATIVE DIABETIC RETINOPATHY; PROSPECTIVE STUDY; PSEUDOPHAKIA; SLIT LAMP; STENT; TRABECULAR MICROBYPASS STENT; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 84946568853     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S91732     Document Type: Article

References (15)

1. Samuelson TW, Katz LJ, Wells JM, Duh Y-J, Giamporcaro JE; US iStent Study Group. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118:459-467.
2. Craven ER, Katz LJ, Wells JW, Giamporcaro JE; iStent Study Group. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012;38:1339-1345.
3. Fea AM. Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma. J Cataract Refract Surg. 2010;36:407-412.
4. Fea AM, Pignata G, Bartoli E, et al. Prospective, randomized, double-masked trial of trabecular bypass stent and cataract surgery vs. cataract surgery alone in primary OAG: long-term data. Presented at: 2012 European Society of Cataract and Refractive Surgeons; September, 2012; Milan, Italy.
5. Spiegel D, Wetzel W, Neuhann T, et al. Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery. Eur J Ophthalmol. 2009;19:393-399.
6. Arriola-Villalobos P, Martínez-dela-Casa JM, Díaz-Valle D, Fernández-Pérez C, García-Sánchez J, García-Feijoó J. Combined iStent trabecular micro-bypass stent implantation and phacoemulsification for coexistent open-angle glaucoma and cataract: a long-term study. Br J Ophthalmol. 2012;96(5):645-649.
7. Bahler C, Smedley G, Zhou J, Johnson D. Trabecular bypass stents decrease intraocular pressure in cultured human anterior segments. Am J Ophthal. 2004;138:988-994.
8. Belovay GW, Naqi A, Chan BJ, Rateb M, Ahmed II. Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma. J Cataract Refract Surg. 2012;38(11):1911-1917.
9. Rulli E, Biagioli E, Riva I, et al. Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures. A systematic review and meta-analysis. JAMA Ophthalmol. 2013;131(12):1573-1582.
10. Spiegel D, Garcia-Feijoo J, Garcia-Sanchez J, Lamielle H. Coexistent primary open-angle glaucoma and cataract: preliminary analysis of treatment by cataract surgery and the iStent trabecular micro-bypass stent. Adv Ther. 2008;25:453-464.
11. O’Connor DJ, Martone JF, Mead A. Additive intraocular pressure lowering effect of various medications with latanoprost. Am J Ophthalmol. 2002;133:836-837.
12. Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension. Clin Ther. 2006;28:552-559.
13. Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112:953-961.
14. Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol. 2008;53(suppl 1):S57-S68.
15. Ahmed II, Katz LJ, Chang DF, et al. Prospective evaluation of microinvasive glaucoma surgery with trabecular microbypass stents and prostaglandin in open-angle glaucoma. J Cataract Refract Surg. 2014;40:1295-1300.